<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>In silico trials of acute ischemic stroke: predicting the total potential for improvement to patient functional outcomes - Health AI Hub</title>
    <meta name="description" content="This study utilized in silico trials (ISTs) to model acute ischemic stroke (AIS) outcomes, quantifying the potential benefit of improved recanalization outcomes">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>In silico trials of acute ischemic stroke: predicting the total potential for improvement to patient functional outcomes</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.02088v1" target="_blank">2511.02088v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-03
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Claire M. Miller, Raymond Padmos, Praneeta Konduri, Tam√°s Istv√°n J√≥zsa, Yidan Xue, Nerea Arrarte Terreros, Max van der Kolk, Stephen Payne, Henk Marquering, Charles Majoie Alfons Hoekstra
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.TO
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.02088v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2511.02088v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This study utilized in silico trials (ISTs) to model acute ischemic stroke (AIS) outcomes, quantifying the potential benefit of improved recanalization outcomes and shorter treatment times. It predicted a significant increase in functional independence for patients with full recanalization and early treatment, highlighting recanalization as more beneficial than faster treatment. This work establishes a novel proof-of-concept for ISTs as a tool to evaluate the maximum potential for improvement to patient outcomes, useful in early therapy development.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This study is crucial for acute ischemic stroke (AIS) treatment as it offers a novel computational method to predict and quantify the maximal achievable improvements in patient functional outcomes. Such insights are vital for prioritizing research and development efforts in neurovascular therapies by identifying the most impactful intervention strategies.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper describes 'in silico trials' (ISTs) which involve creating 'virtual patients' and 'in silico models of blood flow, perfusion, and tissue death' to predict patient functional independence. This represents a significant application of computational modeling and simulation in healthcare, which is a foundational aspect of medical AI. While not explicitly using terms like machine learning or deep learning, the methodology leverages advanced computational techniques for predictive modeling and simulating complex biological systems, which is critical for developing AI-driven personalized medicine, optimizing clinical trial design, and predicting treatment efficacy without extensive human trials.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>In silico trials (ISTs) were used to quantify the maximum potential benefit from improved recanalization and shorter time to treatment for acute ischemic stroke (AIS) patients.</li>
                    
                    <li>The IST framework involved virtual patient cohorts with controlled variables: early (<=4h) vs. late (>4h) treatment and successful (full) vs. unsuccessful (no) recanalization outcomes.</li>
                    
                    <li>In silico models of blood flow, perfusion, and tissue death were used to predict 90-day functional independence, measured by the modified Rankin Scale (mRS).</li>
                    
                    <li>Results predict 57% of the virtual population achieved functional independence (mRS <=2) with full recanalization and treatment within 4 hours, compared to only 29% with no recanalization and treatment beyond 4 hours.</li>
                    
                    <li>Successful recanalization demonstrated a greater benefit for improved mRS (common odds ratio = 2.7) than faster treatment (common odds ratio = 1.6).</li>
                    
                    <li>The study serves as a proof-of-concept for a novel application of ISTs: quantifying the maximum achievable improvement in patient functional outcomes.</li>
                    
                    <li>This methodology is proposed as valuable for early-stage therapy development to identify optimal target populations and therapy goals with the highest potential for population-level improvements.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>An in silico trial (IST) framework was employed, running simulations on virtual cohorts of acute ischemic stroke (AIS) patients. These virtual patients were subjected to varying conditions: early vs. late treatment (<=4h vs. >4h) and successful (full) vs. unsuccessful (no) recanalization. The framework incorporated in silico models of blood flow, perfusion, and tissue death to predict 90-day functional independence using the modified Rankin Scale (mRS).</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>Results predict 57% of virtual patients achieving functional independence (mRS <=2) with full recanalisation and <=4 hours to treatment, significantly higher than 29% with no recanalisation and >4 hours to treatment. Successful recanalisation was found to be more beneficial than faster treatment, with a common odds ratio for improved mRS of 2.7 for recanalisation versus 1.6 for early treatment.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This study establishes a proof-of-concept for using ISTs to quantify the maximal potential for patient outcome improvement in acute ischemic stroke. This capability holds significant clinical impact for the early stages of neurovascular therapy development, enabling researchers to strategically determine target patient populations and define therapy goals that promise the greatest population-level benefits, thereby streamlining R&D efforts and potentially accelerating the delivery of more effective therapies.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract explicitly states this is a 'proof-of-concept' study for a novel use-case of ISTs, implying that while promising, the approach is in its nascent stages and requires further validation, refinement, and possibly larger-scale virtual patient populations before direct clinical application or broader adoption in drug/therapy development pipelines.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The findings suggest a future direction where ISTs are routinely used during the early stages of therapy development. This includes leveraging the framework to identify optimal target populations and therapy goals with the greatest potential for population-wide improvements in acute ischemic stroke outcomes, ultimately guiding resource allocation in neurovascular research.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neurology</span>
                    
                    <span class="tag">Neurovascular Surgery</span>
                    
                    <span class="tag">Stroke Medicine</span>
                    
                    <span class="tag">Computational Biology</span>
                    
                    <span class="tag">Pharmaceutical Development</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">In silico trials</span>
                    
                    <span class="tag tag-keyword">acute ischemic stroke</span>
                    
                    <span class="tag tag-keyword">recanalization</span>
                    
                    <span class="tag tag-keyword">functional independence</span>
                    
                    <span class="tag tag-keyword">modified Rankin Scale</span>
                    
                    <span class="tag tag-keyword">computational modeling</span>
                    
                    <span class="tag tag-keyword">therapy development</span>
                    
                    <span class="tag tag-keyword">odds ratio</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">This study uses in silico trials (ISTs) to quantify the potential for benefit
due to improved recanalisation outcomes and shorter time to treatment for acute
ischaemic stroke (AIS) patients. We use an IST framework to run trials on
cohorts of virtual patients with early and late treatment after stroke onset,
and with successful (full) and unsuccessful (no) recanalisation outcomes. Using
a virtual population of AIS patients, and in silico models of blood flow,
perfusion, and tissue death, we predict the functional independence of each
patient at 90 days using the modified Rankin Scale (mRS).
  Results predict 57% of the virtual population achieve functional independence
with full recanalisation and a treatment time of 4 hours or less, compared to
29% with no recanalisation and more than 4 hours to treatment. Successful
recanalisation was more beneficial than faster treatment: the best-case common
odds ratio (improved mRS) due to recanalisation was 2.7 compared to 1.6 for
early treatment.
  This study provides a proof-of-concept for a novel use-case of ISTs:
quantifying the maximum potential for improvement to patient outcomes. This
would be useful during early stages of therapy development, to determine the
target populations and therapy goal with the greatest potential for population
improvements.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>